<img height="1" width="1" src="https://www.facebook.com/tr?id=1582471781774081&amp;ev=PageView &amp;noscript=1">
Using Tumor Organoids and 3D Ex Vivo Microtumors for Immuno-Oncology Applications

Using Tumor Organoids and 3D Ex Vivo Microtumors for Immuno-Oncology Applications

June 22, 2022

Profiling of Tumor-Infiltrating Immune Cells in Syngeneic Tumor Models to Support Drug Development

Profiling of Tumor-Infiltrating Immune Cells in Syngeneic Tumor Models to Support Drug Development

March 1, 2021

The Rising Importance of GITR Agonists as Alternative I/O Candidates for Combination Drug Strategies

The Rising Importance of GITR Agonists as Alternative I/O Candidates for Combination Drug Strategies

November 30, 2020

Evaluating Immunotherapy Mechanism of Action with Immune Cell Lineage-Specific DTR Models

Evaluating Immunotherapy Mechanism of Action with Immune Cell Lineage-Specific DTR Models

October 14, 2020

T Cell Dysfunction Assays for In Vitro Screening of Immunomodulatory Drug Candidates

T Cell Dysfunction Assays for In Vitro Screening of Immunomodulatory Drug Candidates

September 22, 2020

Digital Pathology

Digital Pathology

July 23, 2020

Immunogenomics in Oncology Drug Development

Immunogenomics in Oncology Drug Development

July 10, 2020

How to Use Tumor Organoids for Immuno-Oncology Applications

How to Use Tumor Organoids for Immuno-Oncology Applications

April 30, 2020

Tumor Organoid Q&A: PDXO Models and Immuno-Oncology Applications

Tumor Organoid Q&A: PDXO Models and Immuno-Oncology Applications

March 16, 2020

huPBMC Humanized Mouse Models: De-Risking Graft versus Tumor (GvT) Effects Through a Co-Culture Donor Selection Assay

huPBMC Humanized Mouse Models: De-Risking Graft versus Tumor (GvT) Effects Through a Co-Culture Donor Selection Assay

February 11, 2020

© 2022 Crown Bioscience.